NIH-funded research R01 grant

Magnetic resonance fingerprinting to gauge chemotherapy response in breast cancer

Official title: Development of Magnetic Resonance Fingerprinting (MRF) to Assess Response to Neoadjuvant Chemotherapy in Breast Cancer

Funded at Case Western Reserve University · NIH-11408782 · Data updated 2026-11-12

A patient-facing look at using a special MRI method (MRF) to see early whether breast cancer is responding to preliminary chemotherapy.

More Breast Cancer research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCase Western Reserve University
NIH-funded
Lab location1 site (Cleveland, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2028
Funding year2026
Award (this year)$634,858
NIH project number5R01CA282516-04
Project IDNIH-11408782 on NIH RePORTER

Who could benefit from this research

Could help

Women with breast cancer undergoing neoadjuvant chemotherapy.

Less likely to help

Patients not undergoing neoadjuvant chemotherapy or not eligible for MRI-based monitoring may not benefit.

What this research studies

This project aims to use an advanced MRI technique to detect biological changes in breast tumors early during neoadjuvant chemotherapy, so doctors can tailor treatment sooner. It focuses on patients with breast cancer who are receiving chemotherapy before surgery. The goal is to predict which tumors will respond well and which will not, potentially reducing unnecessary side effects and guiding adjustments in therapy. The study will work to make this MRI approach practical for routine clinical use. If successful, it could lead to more personalized and effective treatment plans for patients.

Why it matters

Potential benefit: If successful, patients could avoid ineffective therapies and receive more personalized treatment sooner.

How similar studies have gone: Previous work suggests quantitative MRI can reflect tumor biology, but early prediction of NAC response remains an active and likely beneficial area.

Where this research is happening

  • Case Western Reserve University
    Cleveland, United States
    Active

Researchers

  • Principal investigator: Chen, Yong — Case Western Reserve University
  • Study coordinator: Chen, Yong

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.